Cargando…
Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension
Background: Nowadays, it is possible to identify a group at increased risk of preeclampsia (PE) and fetal growth restriction (FGR) using the principles of the Fetal Medicine Foundation (FMF). It has been established for several years that acetylsalicylic acid (ASA) reduces the incidence of PE and FG...
Autores principales: | Tousty, Piotr, Fraszczyk-Tousty, Magda, Golara, Anna, Zahorowska, Adrianna, Sławiński, Michał, Dzidek, Sylwia, Jasiak-Jóźwik, Hanna, Nawceniak-Balczerska, Magda, Kordek, Agnieszka, Kwiatkowska, Ewa, Cymbaluk-Płoska, Aneta, Torbé, Andrzej, Kwiatkowski, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488103/ https://www.ncbi.nlm.nih.gov/pubmed/37685649 http://dx.doi.org/10.3390/jcm12175582 |
Ejemplares similares
-
Low-Dose Aspirin after ASPRE—More Questions Than Answers? Current International Approach after PE Screening in the First Trimester
por: Tousty, Piotr, et al.
Publicado: (2023) -
Effectiveness of Different Algorithms and Cut-off Value in Preeclampsia First Trimester Screening
por: Tousty, Piotr, et al.
Publicado: (2022) -
Adverse Neonatal Outcome of Pregnancies Complicated by Preeclampsia
por: Tousty, Piotr, et al.
Publicado: (2022) -
First-Trimester Fetal Hepatic Artery Examination for Adverse Outcome Prediction
por: Czuba, Bartosz, et al.
Publicado: (2022) -
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers—The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)—An Exploratory Study
por: Bednarek-Jędrzejek, Magdalena, et al.
Publicado: (2022)